The South African Health Products Regulatory Authority (Sahpra) has approved a section 21 emergency-use application for the Covid-19 vaccine developed by Pfizer and BioNTech. Source: BusinessTech
The South African Health Products Regulatory Authority (Sahpra) has approved a section 21 emergency-use application for the Covid-19 vaccine developed by Pfizer and BioNTech. Source: BusinessTech